Diabetes, Heart and Cardiovascular Diseases News Chronicle.  Diabetes, Cardiovascular and Heart Diseases
 Article 316
    Published on March 30, 2018


FDA permits marketing of dermaPACE device for the treatment of diabetic foot ulcers


High blood sugar (or glucose) levels (called type 2 diabetes. T2D) damage small blood vessels and restricts blood supply to nerves. Nerves and nerve fibers will be damaged as the blood rich with essential nutrients, glucose and oxygen could not be delivered to them. An affected individual with nerve damage will lose sensation in those areas. Nerves will become susceptible to infections and injury due to the nerve damage, leading to the development of ulcers. Studies show high blood sugar (or glucose) levels is the major cause of lower limb amputations.

Ads How to reverse type 2 diabetes with a scientifically-proven method!
See More Ads For "Reversal Of Diabetes"

Device for the treatment of venous, arterial, ischemic, diabetic feet, decubitus, pressure (bed) sores and ulcers.

Sanuwave Health, Suwanee, Georgia, the United States, has developed a dermaPACE device, a novel shock wave device for the treatment of acute and chronic wounds or ulcers. "Pulsed Acoustic Cellular Expression" (PACE) technology, a proprietary and patented technology of Sanuwave, was used in the development of this device. This technology uses external high-energy acoustic shock waves (similar to sound waves) to stimulate the wound (or ulcer) and restore normal healing process of the body such as tissue repair and regeneration and growth of blood vessels.

This technology was being used for the past 30 years in medical treatments and procedures. The device was designed for the treatment of chronic, full-thickness diabetic foot ulcers, but not extending to bone level, lasting for more than 30 days. The device can be used for the treatment of ulcer with a size not more than 16cm2. The diabetic foot ulcer treatment as per the guidelines should be followed with the dermaPACE. The device can be used for the treatment of the following.

Ads A simple way to lose belly fat and unwanted body fat
See More Ads For "Lowering Body Fat"

  • Ulcers on the lower leg or ankle area due to vein disease. These ulcers are known as venous ulcers.
  • Ulcers on fingers or toes or on the lateral surface of the ankle. These ulcers are known as arterial ulcers (also known as ischemic ulcers or wounds).
  • Ulcers on foot usually develop due to high blood sugar levels, known as diabetic foot ulcers.
  • Ulcers on skin areas close to bones such as hips, heels, elbows, back and ankles. These ulcers are known as decubitus ulcers (also known as pressure or bed sores).
  • Deep partial thickness burns.
  • Post-traumatic wounds.
  • Post-operative wound healing defects.

Clinical trial for 24 weeks was conducted on 336 patients of diabetic foot ulcer at 39 centers. Prior to trial, participants were under the diabetic foot ulcer treatment as per the guidelines. They were either with well-controlled or poorly controlled blood sugar or glucose levels. Patients were subjected to either with sham dermaPACE treatment plus usual care for wound treatment or active dermaPACE plus usual care for wound treatment. The trial results show.

Ads Dietrine weight loss program helps you to lose weight and to reduce carbs, carbohydrates, and calories
See More Ads For "Body Weight Loss"

  • After 24 weeks of the trial period, patients undergoing dermaPACE system had increased wound healing with a wound closure rate of 44 percent. Patients undergoing sham shock wave therapy had 30 percent of wound closure rate.
  • Recurrence of wounds in the participants under the dermaPACE was less than ten percent.
  • When compared with sham shock wave therapy, there was a significant rate of reduction in the wound area in participants under a dermaPACE system.

There are minimal risks associated with dermaPACE. The common side effects observed with dermaPACE treatment were.

  • Pain during the application of the dermaPACE system.
  • Wound infection, infection in the bone (osteomyelitis) and infection in the inner layers of the skin (cellulitis).
  • A migraine headache.
  • Urge to vomit.
  • Fainting.

Ads This can burn 348% more fat and calories
See More Ads For "Lowering Body Fat"

The dermaPACE, CE marked, has received marketing approval on December 28, 2017, from the United States Food and Drug Administration.

If you like this article, please share it with a friend! Article address is (copy and paste the code below) :

Articles similar to this topic

1. About Diabetic Shoes To Treat Neuropathy
2. Blood Vessel Function Benefits With Weight Lifting Exercises
3. Exercise protein cardiotrophin 1 (CT1) stimulates the growth of blood vessels, helps the growth of heart muscle & ventricle in a healthy way and improves the ability of the heart to pump more blood
4. Diabetic foot ulcers (DFU) could be predicted with SmartMat ™ from Podimetrics
5. Permanent dysfunction of blood vessels with pregnancy preeclampsia condition in women
6. Poor sleeping habits in adults with type 2 diabetes were linked with high blood sugar levels, neuropathic pain and fatigue
7. Hyperglycemia & New AP39 Drug To Prevent Blood Vessel Complications Due To Hydrogen Sulfide (H2S)

Ads Naturally reversing diabetes derived from the bible
See More Ads For "Reversal Of Diabetes"
8. Relief for chronic diabetic nerve pain or neuropathy by blocking HCN2 protein
9. Research On Healing Chronic Foot Wounds
10. Risks With Neuropathy
11. The study shows diabetic foot ulcer patient need a quick review as the condition worsens quickly
12. Study To Treat Diabetic Foot Ulcers
13. Treatment For Diabetic Foot Ulcers
14. Treatment To Diabetic Neuropathy
15. Treatment With ReGenerCell For Diabetic Foot Ulcer
16. Tropical Gel Heals Wounds And Ulcers Fast

Ads The proven 3-point method to melt away ugly body fat in just 15 minutes a day
See More Ads For "Lowering Body Fat"




Site maps

Site map 1   Site map 2   Site map 3   Site map 4

The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of the "Diabetes News Chronicle" website or by the AUTHOR of the article.

Published by Jammi Vasista, Chennai, India.
Email Jammi[no-space]Vasista1991[at]gmail[dot]com
Phone 91-944-578-3182.
Address Diabetes News Chronicle, No 40, Kaveri Street, Rajaji Nagar, Villivakkam, Chennai, India. Pin : 600049.